explaining any syndrome. The difficulty is that all the conditions (e.g., hirsutism, acne, amenorrhea) describing the syndrome mayor may not be present in the person diagnosed with the disorder. Additionally, the conditions represented by the syndrome are, in effect, separate diagnoses. Further, the pathophysiology of the syndrome in its most complete state seems a less than an adequate explanation when the syndrome exhibits itself only partially.
There are two keys to understanding the pathophysiology of pcas. These include understanding the feminizing and masculinizing effects on the body of the hormones estrogen, androgen and testosterone, and progesterone normally secreted by the ovaries and understanding the effects of these hormones on the normal menstrual cycle. The hormone estrogen has feminizing effects including breast development, breast size, deposition of fat cells, and the size of skin pores. Androgenic hormones, of which testosterone is the strongest, have a masculinizing effect such as coarsening of hair, development of facial hair, and lowering of the voice. Progesterone's primary function is to prepare the uterus for pregnancy through proliferation of the uterine lining (Ganong, 1995) . The normal 28 day menstrual cycle can be described as commencing on Day 1 with the onset of menstruation. At the same time a dominant cyst evolves within the ovary. The cyst, known as a follicle, begins to rise to the surface of the ovary. While rising, the follicle begins to secrete estrogen and a small amount of androgen from thecal cells located within the cyst. This initial process takes approximately 14 days. On the 14th day, the follicle, now on the surface of the ovary, ruptures and expels the ovum. The exposed cells of the follicle, called the corpus luteum, begin to secrete progesterone, which prepares the uterine lining for implantation of the ovum in the event of fertilization. Approximately on Day 24 or 25, prior to the end of the menstrual cycle on Day 28, the corpus luteum regresses, causing a withdrawal of progesterone and accompanying deterioration of the endometrial lining, resulting in menstruation. Stein (1935) first identified the syndrome of amenorrhea, hirsutism, and obesity as arising from polycystic ovaries visualized at laparotomy. Until recently, this was thought to develop almost exclusively from an increase in serum luteinizing hormone (LH) (Karim, 1998) . It is now believed PCOS may represent a much more complex disorder, and two types of PCOS may exist-a primarily LH dependent type, and a primarily insulin dependent type. The syndrome as LH dependent can be explained by the notion of a dysfunctional hypothalmus, pituitary, ovarian axis, resulting in a failure to ovulate.
Through feedback, hormones produced by the ovaries normally influence the hypothalamus to secrete gonadotropin releasing hormones (GnRH). This hormone influences the pituitary to secrete LH and follicle stimulating hormone (FSH) in waves or pulses which stimulate an ovarian follicle to arise, secrete estrogen, and, over time, produce an ovum. The failure of the ovary to produce an ovum results in continued secretion and accumulation of high levels of estrogen, unopposed by progesterone, believed to cause suppression of pituitary FSH and a relative increase in LH. Thus, constant LH stimulation of the ovary results in anovulation, multiple cysts, and excess androgen output (Tierney, 2002) .
The second hypothesized type of PCOS is the primarily insulin dependent type. Insulin normally stimulates glucose uptake into tissues. Its ability to do so varies greatly among individuals. In insulin resistant individuals, tissues have diminished glucose uptake ability. The precise way in which insulin resistance develops is unclear, although genetics, diet, and level of physical activity are believed to playa role (Rao, 2001; Slowey, 2001) . This theory suggests PCOS is the product of a metabolic state of insulin resistance in which it is difficult to transfer glucose into cells. The resulting increase in blood glucose signals further secretion of insulin, resulting in a hyperinsulinemic state. Excessive insulin stimulates the insulin sensitive ovary and results in increased androgen production from thecal cell hyperplasia. Additionally, hyperinsulinemia reduces production of sex hormone binding globulin (SHBG), thus increasing the amount of free, unbound testosterone (Balen, 1999) .
THE CLINICAL EXAMINATION
An intermittent examination related to an employee's concern or a history and physical examination which normally accompany employment, might reveal obesity, oligomenorrhea or amenorrhea, and hirsutism. These are often regarded as classic signs and symptoms of PCOS. Additionally other signs of hyperandrogenism, such as acne, oily skin, and virilization may also be present.
Obesity
Central or android obesity is frequently associated with PCOS. Central obesity is defined as a waist to hip 24 ratio of greater than .85 (Slowey, 2001) . For example, a hip circumference of 40 inches and a waist circumference of more than 34 inches at a minimum satisfy the definition of central obesity. It is not unusual to see waist to hip ratio dramatically exceed .85 resulting in a classic pear shape of central obesity as one of the first observations a clinician might make.
Central obesity associated with PCOS typically presents in women as obesity appearing primarily in the abdomen. Obesity places one at risk for numerous diseases such as hypertension, diabetes, dyslipidemia, and heart disease. In women with PCOS, obesity further complicates the hyperestrogenic environment by converting in ovarian and adrenal androgens to estrone peripheral fat cells (Tierney, 2002) .
Oligomenorrhea
A scant or infrequent menses, known as oligomenorrhea, might not be a complaint in the event of an examination in the primary care setting because of most women's reluctance to discuss their menses. Oligomenorrhea is likely to be revealed during the review of systems (ROS), as part of a health history obtained for preemployment purposes where the health status of each system is reviewed and specific inquiry is made related to menses. Irregular, scant menses might not otherwise be noted unless a woman desires pregnancy and relates her irregular or scant menses to infertility.
Oligomenorrhea, a product of the dysfunction in the hypothalmic, pituitary, ovarian axis, and a hyperestrogenic environment, results in anovulation or infrequent ovulation and makes pregnancy a remote possibility. Additionally, the presence of estradiol-not bound by SHBG-and estrone from fat cell conversion of androgens, both of which are unopposed by progesterone, result in the lack of ovulation. This predisposes women to abnormal uterine bleeding and triples the risk of endometrial cancer (Slowey, 2001) .
Hirsutism
Adult women normally have vellus hair covering their body. This vellus hair is fine in texture, short in length, blonde to black in color, and often nearly invisible (Azziz, 2002) . The presence of black hair alone for example, on the cheek, is not hirsutism. Women of Middle Eastern heritage who, by race, often have black hair and olive complexions, have an excess growth of vellus hair referred to as vellus hypertrichosis. This short, dark, soft hair can be bothersome, but is not hirsutism. By contrast, women may become distressed about their appearance with the development of coarse, long, and darkly pigmented body hair referred to as terminal hair. The presence of more than a small number of terminal hairs on the lower abdomen, sternum, abdomen, shoulders, buttocks, inner thighs, upper lip, chin, upper arms, and back is defined as hirsutism (Goolsby, 2001; Secor, 2000) .
Polycystic ovarian syndrome begins with menarche and the signs related to menstruation, obesity, and hirsutism grow worse over time. Hirsutism, initially only minimal at menarche, becomes increasingly problematic as the andrenergic effect of masculinizing body hair becomes greater as the woman ages.
Virilization
The literature related to PCOS usually separates hirsutism, which might be considered a masculine quality, from the notion of virilization. Virilization, as it relates to hair, implies alopecia-loss of scalp hair or thinning scalp hair, or even male pattern baldness. Additionally, virilization may result in alteration of the voice, or increase in muscle mass, hypertrophy of the clitoris, or even atrophy of the breast (Goolsby, 200 I) . Indications of virilization are usually suggestive of androgen excess and may represent conditions other than PCOS.
Integument
Changes in the integument frequently accompany PCOS. Acanthosis nigricans, a near classic and often subtle sign, is not normally detected unless the client is undressed or the clinician is specifically examining for the condition (Azziz, 2002) . Acanthosis nigricans presents as a brown to black darkening of the skin at the anterior base of the neck, spreading laterally and often onto the upper thorax and shoulders, and in a U shaped pattern at the underarms. The texture is often referred to as velvety in appearance (Fitzpatrick, 2001) .
The author has encountered primary care clients who viewed the presence of acanthosis nigricans as inconsequential. One client attributed the condition to a dye she encountered in the workplace, and was unable to explain why other parts of her body were unaffected. Thus, acanthosis nigricans is not a condition usually presented as a complaint, but one that must be examined with some increased index of suspicion or it will likely be missed. Further, coarsening of the skin described as the increasing size of skin pores, acne, and acrochordons (i.e., skin tags), has also been attributed to PCOS and may be androgenic in origin (Falsetti, 2000; Goolsby, 2001; Michelrnore, 1999; Secor, 2000) .
Diagnostics
The diagnosis and treatment of PCOS is, at minimum, the role of an advanced practice nurse. Occupational health nurses are guided in their practice by their respective State Boards of Nursing or other licensing agencies which oversee the practice of nursing. Thus, the act of diagnosis and treatment of conditions such as PCOS mayor may not fall into that practice parameter. By contrast, nonpharmacotherapeutic modalities addressing health promotion and disease prevention related to PCOS or the conditions which might accompany PCOS are very much within the practice parameters of professional nursing. The spectrum of the disorder is so broad that women may present with one, all, or any combination of features from the most mild to extreme form. The extent to which the features are investigated to exclude other disease processes is clinical judgment based on client presentation and clinician expertise.
Polycystic ovarian syndrome is a diagnosis of exclusion requiring the presence of hirsutism, evidence of ovar-ian dysfunction, and obesity (Azziz, 2002; Falsetti, 2000; luorno, 1999; Karim, 1998; "Polycystic Ovary Syndrome," 200 I; Slowey, 200 I; Stein, 1935; Tierney, 2002) . Additionally, employee concerns, as well as signs and symptoms revealed by a thorough history and physical examination, might include changes in the integument such as oily skin, acne, alopecia, or acanthosis nigricans, and, at the extremes, virilization (Azziz, 2002) .
The features usually appear at adolescence and grow worse over time. Further, Dunaif (2001) reports family studies suggest a strong genetic influence. Polycystic ovarian syndrome and hyperandrogenism are present in approximately 50% of affected sisters with similar clustering in sisters of insulin resistance and elevated low density lipoprotein.
The signs and symptoms revealed by the history and physical might suggest PCOS. Establishing PCOS LH dependent type as the diagnosis requires the elimination of other diagnostic possibilities which Tierney (2002) Further, in the presence of the rapid progression in signs and symptoms of virilization, radiography is needed to rule out tumors (Azziz, 2002) .
The literature currently offers two hypothetical explanations for PCOS. In the LH dependent hypothesis, the cysts found on ovaries produce an androgenic environment resulting in the signs and symptoms of PCOS. In the second, more recent hypothesis, insulin resistance produces an environment of hyperinsulinemia, which acts on the ovary producing cysts and the conditions resulting in the signs and symptoms of PCOS.
Establishing the diagnoses of PCOS insulin resistant type is much more problematic. Currently, there is no identified gold standard for establishing the presence of insulin resistance in the absence of diabetes-only recommendations. Insulin resistance can only be suggested by clinical signs of PCOS and impaired glucose metabolism demonstrated in the laboratory by: • Fasting glucose level of 110 to 125. • Impaired 2 hour glucose tolerance test (GTT) of 140 to 199 (Rao, 2001; Slowey, 2001 ). • Fasting insulin ratio of less than 4.5 (Secor, 2000; Slowey, 2001) .
THERAPEUTIC MODALITIES
The treatment for PCOS is often focused on the conditions of obesity, oligomenorhea or amenorrhea, hirsutism, acne, and oily skin. Polycystic ovarian syndrome is a disease process in which a single therapeutic modality has broad effects and may result in resolution of multiple concerns. For example, the first line therapy for PCOS is weight loss diet and exercise (Iuorno, 1999; Karim, 1998) . Diet and exercise directed toward obesity can result in weight loss, return to a normal menstrual cycle, and resolution of hirsutism, acne, and oily skin, reversing the symptoms of PCOS (Homburg, 2002) .
The literature reveals the ideal diet for PCOS is up for debate CPolycystic Ovary Syndrome," 2001). Thus, it is not unreasonable to assume any number of commonly used and nutritionally sound diet plans would result in weight loss and reduced peripheral fat cells. Reducing fat cells decreases the sites available to convert ovarian and adrenal androgens to estrone (Tierney, 2002) . A significant number of women may return to full ovulatory function with as little as 5% to 7% weight loss (Slowey, 200 I) . The effectiveness of diet and exercise as a modality does not make it more attractive as an option, nor if chosen, make compliance certain. The occupational health nurse might help greater numbers of workers to adjust to a new dietary lifestyle through counseling related to diet, reinforcement of good health habits, and communication about short term and long term goals.
The current standard therapy for PCOS is oral contraceptives [OCs] . Oral contraceptive therapy may resolve numerous problems associated with PCOS. Oral contraceptives affect the ovary by maintaining a constant level of estrogen and progesterone in the body. This prevents the normal functioning of the hypothalmic pituitary ovarian axis and eliminates the normal stimulation of the hypothalamus and pituitary function by the fluctuation of estrogen and progesterone hormones which normally occur as part of the menstrual cycle. Thus, OCs manage oligomenorrhea and reduce the risk of endometrial hyperplasia, cancer, dysfunctional uterine bleeding, and pregnancy (Azziz, 2002) . Additionally, OCs have an anti androgen effect by preventing the small amounts of testosterone produced normally as part of the menstrual cycle. The prevention of testosterone production for several cycles results in decreases in hirsutism (Falsetti, 2000; Goolsby, 2001) , and acne (Dickey, 2002) .
Two of the preferred oral contraceptives in the treatment of PCOS are Desogen and Orthocept. These third generation OCs contain desogestrel as the progesterone component. According to Dickey (2002) , desogestrel can increase SHBG by 320% to 350%, reducing free testosterone by 50% to 55%. The antiandrogen effect of OCs can be increased by the addition of spironolactone, a powerful antiandrongen (Falsetti, 2000) . Spironolactone is particularly useful for hirsutism in women whose hair growth is unresponsive to OCs (Slowey, 2001) .
Acne and hirsutism can be managed as separate processes. Hirsutism can be treated with electrocautery therapy or laser therapy in which the root of each hair is destroyed. Additonally, a new pharmacotherapy for facial hair, eflomithine (Vaniqa), slows and minimizes hair growth and makes hair less visible and coarse (Azziz, 2002) . Laser therapy, currently recommended for dark hair on light skin, may soon expand recommendations based on advances in laser technology (Azziz, 2002) .
Recent articles on PCOS have touted metformin (Glucophage) a drug for the treatment of insulin resistant diabetes as therapy for PCOS (Homburg, 2002; Iuorno, 1999; Rao. 200 I; Slowey, 200 I) . The use of metformin is 26 based on the hypothesis of PCOS as primarily resuio ng from insulin resistance and resulting hyperinsulinernia Therefore, a decrease in insulin resistance reduces the effect of insulin on the ovary. Complicating this possible cause and effect relationship is that insulin resistance in the absence of hyperglycemia (diabetes) is a diagnosis for which no gold standard of certainty exists. Further, metformin is not labeled for treatment of insulin resistance in the absence of diabetes (Rao, 200 I) .
INTERVENTION STRATEGIES
When encountering employees with PCOS, the degree to which each employee desires to know about her condition must be individualized through ongoing assessment of learning needs. For whatever reasons some employees may not desire any knowledge related to their health. By contrast, some may desire the fullest extent of the occupational health nurse's skill to resolve their learning needs.
A brief discussion related to feelings and the meaning related to those feelings with employees diagnosed with PCOS provides clear direction for teaching efforts. The nurse may find these women are struggling with problems unimaginable to most men. Most of these women do not know where to look for help (Obesity, Fitness, & Wellness Week, 2001) .
Polycystic ovarian syndrome and accompanying oligomenorrhea and amenorrhea place women at increased risk for endometrial hyperplasia from constant estrogen stimulation. These clients should be counseled to have yearly pap smears because of their increased risk for cancer. Additionally, oligomenorrhea and amenorrhea result in unpredictable ovulation or lack of ovulation, making pregnancy difficult to impossible. Women should be counseled that medication such as clomiphene can be prescribed to increase their likelihood of conception.
The most commonly recommended treatment for PCOS is diet and exercise. Long term success related to weight loss and exercise require significant lifestyle changes which often overwhelm short term accomplishments. Unfortunately, both short term and long term compliance are often poor without proper, structured guidance. The known success of weight loss as a treatment for PCOS may test the ethical limits of advanced practice nurses who may be tempted or pressured to prescribe metformin therapy under the pressure of metforrnin's near "urban legend" ability to assist in weight loss.
Changes in the integument, hirsutism, and acne can cause significant emotional distress (Secor, 2000) . Dark hair on a woman's body in otherwise hairless areas or areas normally covered with downy hair is seen as masculine and threatening to the view of a feminine image. Women should be discouraged from plucking, waxing, or unnecessary shaving, all of which can worsen the hirsute condition. Over time, mild to moderate acne can often be resolved by OCs or other antiandrogens. During this resolution process or in more resistant cases, acne can be treated as a pilosebaceous problem treated with comedolytic agents such as topical tretinoin (Retin-A), or mildly inflammatory acne can be treated with topical antibiotics such as erythromycin 2% solution.
